Task: Answer Verification
Input (English): Question: Do iFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection?
Answer: This adequately powered study in patients with HCV genotypes 2 or 3 infection clearly demonstrates that IFNL3 genotypes are the strongest baseline predictor of SVR, in keeping with the known association for genotype 1 infection. IFNL3 genotyping can aid in therapeutic decision making for these patients.
Output (English): yes